Xydalba (dalbavancin)
Acute Bacterial Skin and Skin Structure Infections
ApprovedActive
Key Facts
Indication
Acute Bacterial Skin and Skin Structure Infections
Phase
Approved
Status
Active
Company
About Angelini Pharma
Angelini Pharma is a century-old, private Italian pharmaceutical company with a significant international commercial footprint across Europe and the United States. Its strategy is built on a diversified portfolio spanning prescription drugs in Brain Health, Specialty Care, and over-the-counter Consumer Healthcare products. The company demonstrates a clear commitment to its core therapeutic areas through ongoing commercial initiatives, medical education platforms like Headway, and a pipeline that includes recently launched CNS products such as Ontozry.
View full company profile